Guided Therapeutics Return on Equity (ROE) Growth & History (GTHP)

Guided Therapeutics's return on equity was −1,406.43% for fiscal 2013.

View full Guided Therapeutics company overview

Guided Therapeutics annual return on equity history

Guided Therapeutics annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20132013-12-31−1,406.43%−1085.18 pp
20122012-12-31−321.25%+191.80 pp
20112011-12-31−513.05%

Guided Therapeutics return on equity trends

Between the periods ended 2011-12-31 and 2013-12-31, Guided Therapeutics's return on equity decreased from −513.05% to −1,406.43%, a change of −893.38 percentage points. The latest reported quarter, Q4 2013, shows −1,066.02%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Guided Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about GTHP yet. Start the conversation.

Write the first post